Correlation Between Kezar Life and Ocular Therapeutix

Can any of the company-specific risk be diversified away by investing in both Kezar Life and Ocular Therapeutix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Ocular Therapeutix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kezar Life Sciences and Ocular Therapeutix, you can compare the effects of market volatilities on Kezar Life and Ocular Therapeutix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Ocular Therapeutix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Ocular Therapeutix.

Diversification Opportunities for Kezar Life and Ocular Therapeutix

0.56

Correlation Coefficient

Kezar Life  Ocular Therapeutix

Very weak diversification

The 3 months correlation between Kezar and Ocular is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Ocular Therapeutix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocular Therapeutix and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Ocular Therapeutix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocular Therapeutix has no effect on the direction of Kezar Life i.e., Kezar Life and Ocular Therapeutix go up and down completely randomly.

Pair Corralation between Kezar Life and Ocular Therapeutix

Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Ocular Therapeutix. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 2.25 times less risky than Ocular Therapeutix. The stock trades about -0.3 of its potential returns per unit of risk. The Ocular Therapeutix is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  869.00  in Ocular Therapeutix on September 17, 2024 and sell it today you would earn a total of  0.00  from holding Ocular Therapeutix or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Kezar Life Sciences  vs.  Ocular Therapeutix

Kezar Life Sciences

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.

Ocular Therapeutix

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ocular Therapeutix are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Ocular Therapeutix is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Kezar Life and Ocular Therapeutix

The main advantage of trading using opposite Kezar Life and Ocular Therapeutix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Ocular Therapeutix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocular Therapeutix will offset losses from the drop in Ocular Therapeutix's long position.

The idea behind Kezar Life Sciences and Ocular Therapeutix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.